chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 20-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported.
Flu like symptoms; Pain in her arms; Muscle pain; Joint pain; Headache; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Pain in her arms), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and HEADACHE (Headache) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Pain in her arms), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Pain in her arms), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Patient was given pediatric Pfizer despite confirming DOB. Vaccine administered at a vaccination of mostly pediatric Pfizer. Patient should have been given adult/adolescent Pfizer. Per CDC guidelines, the 2nd dose of the primary series will be the adult/adolescent Pfizer. No adverse reaction observed.
1 degree elevation fever Muscle aches Rapid pulse -- about 100 for 12 hours
Within 6 hours, fatigue, headache, vomiting, dizzy, back ache, every joint in body hurt... joints continue to hurt for 3 days, headache  anf fatigue still present 5 days later,  Dizzy spells,  severe stomach pain and back ache continued ...
pt recvd vax & 1 day p/vax exp flu (fever, coughing, cold); seen by MD prescribed Cipro for 5 days; sx resolved;
11am sudden onset of Left sided weakness, ataxia, dilated and non-reactive right pupil, double vision and tingling down left arm for 15 minutes. Transported to ED via private  vehicle. CT and CTA negative for acute intracranial pathology but infused with tPA and transferred to Hospital for  continued work up and post tPA infusion care.
Arm soreness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm soreness). At the time of the report, PAIN IN EXTREMITY (Arm soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication and treatment information was provided.
Body aches; Chills; Headache; This is a spontaneous report from a contactable consumer (patient). This 37-year-old male patient received the second dose of BNT162B2 (UNSPECIFIED TRADE NAME; lot number EL3247) via an unspecified route of administration in the left arm on 17Feb2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history, was not allergic to medications, foods or other product, and was not diagnosed with COVID-19 prior to vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (lot number EL3247) on 27Jan2021 at 10:00 (at the age of 37-years-old) in the left arm for COVID-19 immunisation. On 18Feb2021 the patient experienced body aches, chills, and headache. The events were reported as non-serious and did not require hospitalization. No treatment was provided for the events. The clinical outcomes of body aches, chills and headache were recovering. It was also reported that since the vaccination the patient had not been tested for COVID-19.
10 hours after injection, I woke up with a splitting headache, 100.4 fever, fatigue, body aches, vomiting  This lasted for approximately 20 hours.  Then my fever broke and felt about 80% better.  Fever, body aches and fatigue came back at the 25 hour mark post injection and lasted until 6:00am or 39 hours post injection time.  Tylenol, Motrin and Pedialyte was taken.    Slight fatigue and weakness still at 60 hours.
tested positive on COVID-19 rapid antigen test today; tested positive on COVID-19 rapid antigen test today; This is a spontaneous report received from contactable reporter(s) (Pharmacist).  A 56-year-old female patient received BNT162b2 (BNT162B2), on 25Jan2021 as dose 1, single (Batch/Lot number: unknown), on 17Feb2021 as dose 2, single (Batch/Lot number: unknown), on 03Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 19May2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 12Jun2022, outcome "not recovered" and all described as "tested positive on COVID-19 rapid antigen test today". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (12Jun2022) Positive. Clinical course: patient tested positive on COVID-19 rapid antigen test today (i.e. 12Jun2022). Her symptoms were tiredness and headache over the last two days and rapid heartbeat today(i.e. 12Jun2022). No other respiratory symptoms. She was a subject in the COVID-19 clinical study.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the events cannot be completely excluded.
Patient has hx of seizures  well controlled no seizures for one year  with in 15 minutes of Moderna vaccine had Generalized Seizure lasting > 10 mins no  hypoxia   transferred to local ED  patient was dc the same day to follow up with neurology in good condition
Pt recv vax on 12/4/98; on same day pt exp stiff neck & spine; tingling of hands; tx=Advil
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 58 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PANTOPRAZOLE; VITAMIN D NOS; CALCIUM. Past drug history included: Aspirin, reaction(s): "Known allergies: Aspirin". The following information was reported: DRUG INEFFECTIVE (medically significant), outcome " not recovered ", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (unspecified date) Negative, notes: tested negative for a week; (01May2022) Positive, notes: I tested positive for Covid again today. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient received other medications (Concomitant medications) in 2 weeks. Paxlovid was given for COVID 19 Treatment on 19Apr2022 and stopped on 24Apr2022. The patient stated that I finished Paxlovid and recovered and tested negative for a week. Then all of my symptoms returned, and I tested positive for Covid again today.  The lot number for [BNT162b2], was not provided and will be requested during follow up.
Patient age 17 was administered Janssen (J&J) vaccine on the red mobile unit.  Age limit for Janssen is 18.
Diarrhea; Coughing; Coughed all night; Sore throat; I am a sick person; I started to feel sick; I feel very weak; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (BNT162B2 OMI XBB.1.5), on 06Oct2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COUGH (non-serious) with onset Oct2023, outcome "unknown", described as "Coughing; Coughed all night"; DIARRHOEA (non-serious) with onset Oct2023, outcome "unknown", described as "Diarrhea"; ILLNESS (non-serious) with onset Oct2023, outcome "unknown", described as "I am a sick person; I started to feel sick"; ASTHENIA (non-serious) with onset Oct2023, outcome "unknown", described as "I feel very weak"; OROPHARYNGEAL PAIN (non-serious) with onset Oct2023, outcome "unknown", described as "Sore throat".  Additional information: Patient had the shot for COVID (Pfizer COVID-19 vaccine) on the 6th of this month and started to feel sick and then had diarrhea and coughing and coughed all night and had a sore throat. Patient felt very weak and wanted to know what can be done for this.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Site: Pain at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Visual Changes/Disturbances-Mild
MA accidentally given Hep A to 4 week old instead of first Hep B dose. No adverse signs to report, patient reported today to clinic, had no symptoms, received 2 month vaccinations with no adverse reactions.
After the patient received the vaccine, she became pale,and started to fall to the floor. After the patient was lowered to the floor, she became diaphoretic, pale, and her B/P and pulse were high. She was then returned to the exam room and placed in the Trendelenberg position and monitored. After 15 minutes, pulse and B/P returned to normal and the patients color was normal. The patient stated she felt fine, and was walked to the car with her mother and staff present. In a follow up call 1.5 hours later, the patient stated she was feeling fine and had no further problems.
Prior to receiving the Moderna Covid-19 Booster shot, I had been regularly getting my period for three days maximum. These periods had been mostly spotting with little to no cramps and pain. On January 13th, 2022, less than 24 hours after receiving my shot, I experienced immense pain and cramps in my lower abdomen.  I proceeded to be met with an extremely heavy period that did not subside for over three weeks.
Crusty, bleeding slits, in corner of mouth. Could not eat. Eczema.
Continual aches and pains in hips and lower back: treated with acetaminophen  Continual Nausea  Vomiting Diarrhea
patient just reported red spots on the legs about 7 days after injection, not itchy or painful
Child began running a fever of 103.5 3/24/16 at 6:00pm. Fever continued until 3/25/16 at 5:00pm. Child woke up with rash on chest on 3/26/16 and was very cranky and had a loss of appetite. Rash spread to back, face, neck, and arms on 3/27/16 and patient was still cranky and would no eat. Rash was less predominant on 3/28/16 and was gone by 3/29/16.
1st injection on evening of  Feb. 18, 2021,  resulted only in sore arm for maybe 36 hours and feeling fairly tired the next fully day. 2nd vaccine, 2 p.m. on March 12, 2021, resulted initially in mildly sore arm.  By end of next day or possibly day after that, I had developed tender, slightly itchy swelling around injection site on left arm.  Swelling was a few inches long and a couple of inches wide.  At the same time, I started experiencing pain in various parts of that arm and hand ranging from discomfort to fairly sharp pain, with location and amount of pain varying from day to day.  This lasted for two full weeks.   I can't explain why, but rather than being only a direct result of the vaccine, my perception was that somehow the injection had triggered the fibromyalgia in that arm and only that arm.   Whether it was the physical process of the shot or the medication, I can't say.   It wasn't debilitating, but it was definitely unpleasant.
Patient stated had allergic reaction, started with feeling under the weather that day (Thur), on following  Mon high fever started which persisted for couple of days then rash developed couple days later. Rash started on arms, progressed to chest then legs and neck/face. Rash got progressively worst and pt went to see md. They treated her with IV steroids and antihistamines. Patient stated still has full body rash and still getting treatment but symptoms are getting better.
Developed hives on arms and upper body in the afternoon of 05/03.  By evening, I had a rash all over with the exception of hands, feet, and face.  Took two benadryl in the evening as well as one Zyrtec.  The welts and swelling on arms had subsided by morning (still visible though) but was stronger on legs.  Developed swelling in hands and arm overnight as well.  Taking more benadryl today and monitoring to see if further treatment is needed.
Patient woke approximately 2 days later to a burning mouth sensation. They have become blister like and puffy. Pt saw PCP on 11/15/17. Hurts to laf. Tried lysine but was told to see Doctor. Doctor also looking to adverse event upon start of losartan 100mg tablets close to possibly 1 week prior to vaccination. Doctor told patient to continue losartan and to call/be seen if symptoms worsen/continue.
Patient became hypoxic with chest pain. Wheezing noted throughout lung fields. SPO2 80% on room air. Tachycardic 115 with decreased level of consciousness. Admitted to hospital with diagnosis of COPD exacerbation with Hyperkalemia (6.2). Currently stabilized on O2 at 3l/m
Shingrix was inadvertantly administered earlier than the 2month interval; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 72-year-old male patient who received Herpes zoster (Shingrix) (batch number 52R7X, expiry date 10th October 2021) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 15th November 2019, the patient received Shingrix. On 15th November 2019, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: Additional details were provided as follows: The pharmacist called to report that Shingrix was inadvertantly administered earlier than the 2month interval. First dose was 8th October 2019, second dose was 15th November 2019, which led to drug dose administration interval too short. The reporter was consented to follow up.  The Lot and expiration date was from 2nd dose.
the clinic nurse administered a 4th dose of the Covid vaccine in error. The patient had received his booster prior to being admitted, offsite on January 19,2022. The nurse neglected to add the 3rd dose when entering immunization history into our EMR which resulted in the patient receiving an additional booster in error. The patient reported 12 hours of fever like symptoms with 2 episodes of vomiting. Per conversation with guardian, all symptoms had resolved within 24 hours of onset. Patient reports no further issues per guardian at last phone contact on 04/22/2022.
Patient reports prolonged fever, headache, body aches, muscle aches, fatigue. Still continuing 5 days after injection of 2nd dose. Patient also describes a pruritic rash to left arm (injected arm) that is described as having some small bumps and red blotches the size of quarter. Patient experienced no side effects from 1st dose.
Arm pain, weakness.  Pins and needles in arm and moving to hand and wrist. and ringing in my ears.  Still.  Got shot May 21st still have symptoms.  Appointment with doctor October 7th.
Developed hives itching and rash all over. Have since received diagnosis of chronic spontaneous urticaria, taking xolair to control it.  Dr says no more COVID vaccinations
Initial report received on 22 September 2009 from a health care professional. A 41 year old female patient with no reported medical history experienced symptoms after vaccination with FLUZONE (Lot number U3173CA) intramuscularly in the left deltoid, and an intradermal left forearm administration of TUBERSOL 5 TU (lot number number C3151AA) on 21 September 2009. The same day, post vaccination the patient developed tachycardia of 110/minutes and an increased respiratory rate of 30/minutes which cleared by the morning. However, the patient awoke with a stiff neck. No further information was reported. The recovery status was reported as unknown. Follow-up information received on 09 November 2009 from a health care professional. The patient had no concurrent illnesses, pre-existing medical conditions or use of other medications at the time of vaccination on 21 September 2009. The patient had no other vaccinations within four weeks of 21 September 2009; and adverse events with prior vaccinations were reported as "N/A". The patient recovered (date not provided). No further information is expected. List of Documents held by Sender: none.
Fever 100.9, body aches, chills, sweats, headache, vomiting, left arm numbness
Arm pain happened 4 hours after vaccination.; Dizziness; weakness; heart rate went to 140 30 minutes after the shot. Heart rate went down 1 hour after; This is a spontaneous report from a contactable consumer. This 25-year-old female consumer (patient) reported that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose for COVID-19 immunization on 18Jan2021 at 13:00.  Relevant history and concomitant drugs were unknown. No known allergies. No other medical history. The patient received her first dose of BNT162B2 on unknown date. The patient experienced dizziness and weakness on 18Jan2021 at 01:45 pm. The heart rate went to 140 30 minutes after the shot. Heart rate went down 1 hour later, but she was still having dizziness. The patient also had arm pain 4 hours after vaccination on 18Jan2021. No treatment was received. The outcome of event was recovering.  The patient did not receive any other vaccine in four weeks. The patient did not have COVID infection prior vaccination. The patient did have COVID test post vaccination.   Information about Lot/Batch number is requested.
Body aches; Sore injection site; Nausea; This is a spontaneous report from a contactable consumer. A 61-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection, Batch/Lot Number: EL9269), via an unspecified route of administration, administered in Arm Right on 09Feb2021 15:30 as Single Dose for covid-19 immunisation. Medical history included drug hypersensitivity (Sulfa allergy), thyroid disorder and hypertension from an unknown date and unknown if ongoing. Concomitant medications included levothyroxine, liothyronine (NP THYROID) from unspecified date to unspecified date for unknown indication. On 09Feb2021 23:00, The patient experienced body aches, sore injection site and nausea. The action taken in response to the events for BNT162B2 was not applicable. Outcome of events was not recovered.
felt tired / "worn out" (he could not describe the feeling more accurately); fever; chills; Nausea; This is a spontaneous report from a non-contactable consumer. A male patient in his mid-30  received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number and Expiration date was not reported), via an unspecified route of administration on 11May2021, as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number and Expiration date was not reported), via an unspecified route of administration on an unknown date, as single dose for COVID-19 Immunization. On Wednesday, 12May2021, around 3-4 AM, the patient began to feel like he had fever and chills. He also felt some nausea and worn out (he could not describe the feeling more accurately). On Thursday, 13May2021, the patient felt tired but had no nausea and by Friday, 14May2021, the patient felt better. The outcome of the event nausea was resolved whereas the outcome of the events fever, chills, worn out and fatigue was unknown.  Follow up (24May2021): This is a follow up spontaneous report in response to mail trail sent regarding the confirmation of the query. This reported included reporter country.  Follow up attempts are completed. No further information is expected.
Pt received the vaccines ~0915 on 11/12/18. He tolerated the injections well, was provided with a snack, & was monitored in the health center for ~20-25 min following the vaccine administration. He reported feeling well & was sent back to class about 0945. He returned to the health center ~1205 with c/o headache & bilateral arm pain (at site of injections, but R deltoid > L deltoid), along w/ intermittent blurry vision & difficulty concentrating. Around 1215, he also began to c/o nausea. He reported the bright lights & loud noise in his classroom had seemed to make his s/sx worse, but the s/sx seemed to be slightly improved once he got to the health center. We checked his blood glucose, vital signs, and gave him 1000mg acetaminophen & 1000mg TUMs, along with some trail mix and water. He reported resolution of his symptoms after ~45 min and he was discharged back to class.
RIGHT ARM IS EXTREMELY SORE AND CRAMPING ALL THE WAY DOWN (MAINLY IN THE UPPER ARM).  FEELS AS THOUGH IT IS BRUISED AND HAS FEVER IN A 4 TO 6 INCH DIAMETER AROUND SHOT AREA, AS WELL AS HIVES (RAISED WITH WHELPS, ITCHING AND REDNESS).  WHOLE UPPER ARM IS SORE TO TOUCH.  FIRST NOTICED REDNESS & CRAMPING 10-23-06 8:00 AM.  FIRST NOTICED SORENESS 10-20-06 6:00 PM.  EXTREME SORENESS NOTED 10-21-06 2:00 PM. EXTREME SORENESS IS GETTING BETTER NOW (10-23-06 10:15 PM), BUT IS STILL VERY SORE.